Brian Rosen
Vice President, Commercial Strategy

Mr. Rosen is Senior Vice President, Commercial Strategy with responsibility for leading commercial strategy efforts instrumental to ensuring future patient access to Novavax’ vaccines. Mr. Rosen joined Novavax in 2015 as Vice President, Market Access and Policy and was named Vice President, Commercial Strategy in June 2018. He came to Novavax with more than 20 years of industry, legal and patient advocacy experience, the vast majority engaged in government affairs, advocacy, reimbursement and policy work. Prior to Novavax, Mr. Rosen was most recently the Chief Policy, Advocacy and Patient Access Officer for the Leukemia & Lymphoma Society, where he oversaw all legislative and regulatory efforts and the delivery of patient services nationwide, and, prior to that, developed and ran the Government Affairs, Policy and Alliance Development functions for MedImmune. Mr. Rosen currently serves as Chair of the Board of Directors of MdBio Foundation, a non-profit that provides STEM education and workforce development to underserved communities. Mr. Rosen received his Bachelor of Arts degree in History and Psychology from Tufts University and his Juris Doctorate from Hofstra University School of Law.